Hong Kong

2 Vaccines Approved for Use in Hong Kong

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
Approval Source: reuters.com

6 in Clinical Trials in Hong Kong

RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
42 trials in 10 countries
DNA

The University of Hong Kong

SARS-CoV-2 DNA Vaccine

Replicating Viral Vector

The University of Hong Kong

DelNS1-nCoV-RBD LAIV

Inactivated

Sinovac Biotech (Hong Kong) Limited

COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain